WEE1-IN-13
WEE1-IN-13 (Compound 10) is a highly selective WEE1 kinase inhibitor (IC50=0.7 nM) . WEE1-IN-13 abrogates the G2/M checkpoint and induces tumor cell apoptosis. WEE1-IN-13 is promising for research of solid tumors (e.g., non-small cell lung cancer, ovarian cancer) [1].
Product Specifications
UNSPSC
12352005
Target
Wee1
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
C[C@H](C1=C(C2=C(N1C)N=C(N=C2)NC3=CN(N=C3)C4CCN(CC4)C)C#N)C5=CC=CS5
Molecular Formula
C23H26N8S
Molecular Weight
446.57
References & Citations
[1]Knight JL, et al. Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study. Nat Commun. 2025 Aug 26;16 (1) :7962.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC700391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880485-100 1x 100 µL
ODC-1 (Ornithine Decarboxylase-1) (ODC1/485), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942967-500 1x 500 µL
HLA-Pan (MHC II) (HLA-Pan/2967R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941906-500 1x 500 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (rCHGA/413), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details